PDE4B-IN-6
PDE4B-IN-6 (compound 4i) is a potent and selective PDE4B inhibitor with an IC50 of 7.42 nM. PDE4B-IN-6 shows ~195- and ~169-fold selectivity for PDE4B over PDE4A (IC50 = 1540 nM) and PDE4C (IC50 = 1260 nM), respectively. PDE4B-IN-6 increases cAMP level and suppresses TNF-α expression. PDE4B-IN-6 shows favorable antioxidant profiles and low cytotoxicity. PDE4B-IN-6 can be used for chronic obstructive pulmonary disease (COPD) research[1].
Product Specifications
UNSPSC
12352005
Target
Phosphodiesterase (PDE) ; TNF Receptor
Related Pathways
Apoptosis; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C(NNC(C1=CC=C(OC(F)F)C(OCC2CC2)=C1)=O)C3=CC(OC)=C(OC)C(OC)=C3
Molecular Formula
C22H24F2N2O7
Molecular Weight
466.43
References & Citations
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-179504/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE4
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
